216 related articles for article (PubMed ID: 11849221)
1. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients.
Preston FE; Laidlaw ST; Sampson B; Kitchen S
Br J Haematol; 2002 Mar; 116(3):619-24. PubMed ID: 11849221
[TBL] [Abstract][Full Text] [Related]
2. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic interventions for reversing the effects of oral anticoagulants.
Kalus JS
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
[TBL] [Abstract][Full Text] [Related]
4. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
5. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
Pabinger-Fasching I
Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
7. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.
Bruce D; Nokes TJ
Crit Care; 2008; 12(4):R105. PubMed ID: 18706082
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
13. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
[TBL] [Abstract][Full Text] [Related]
15. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
16. Results of Octaplex for reversal of warfarin anticoagulation in patients with hip fracture.
Ng R; Shabani-Rad MT
Can J Surg; 2019 Feb; 62(1):14-19. PubMed ID: 30265643
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
[TBL] [Abstract][Full Text] [Related]
18. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural warfarin reversal with prothrombin complex concentrate.
Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
[TBL] [Abstract][Full Text] [Related]
20. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
Yamamoto R; Nakae Y; Tanaka F; Johkura K
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]